Chiropractors in Readfield, ME Accepting Medicare

2 Chiropractors found. Showing 1 - 2

Cotone Family Chiropractic Llc Chiropractor Medicare: Medicare Enrolled Practice Location: 169 South Rd, Readfield, ME 04355 Phone: 297-620-2078

Jennifer L Cotone, D.C. Chiropractor Medicare: Medicare Enrolled Practice Location: 169 South Rd, Readfield, ME 04355 Phone: 207-620-2078

News Archive

GW SPHHS to hold public forum on prevalence and impact of eating disorders

The George Washington (GW) University School of Public Health and Health Services (SPHHS) will hold a public forum on February 25 that will address the prevalence and impact of eating disorders, especially on college campuses.

EnzymeRx commences patient enrollment in Uricase-PEG 20 phase 1 study

EnzymeRx, LLC (www.enzymerx.com), a clinical-stage biotechnology company, announced that it has launched its first clinical study of Uricase-PEG 20. Subjects have begun enrolling in a phase 1 safety, pharmacokinetic and pharmacodynamic study of single intravenous doses of Uricase-PEG 20.

Senate HELP committee to hold confirmation hearing on FDA commissioner nominee

The Senate Health, Education, Labor and Pensions Committee on Thursday will hold a confirmation hearing for Margaret Hamburg, President Obama's nominee for FDA commissioner, the New York Times reports.

S*BIO begins SB1317 Phase 1 clinical trial in patients with advanced/refractory hematologic malignancies

S*BIO Pte Ltd today announced that a fourth novel, potential best-in-class compound discovered and developed by S*BIO has entered a Phase 1 clinical trial. The initiation of the study for S*BIO's oral multi-kinase inhibitor, SB1317 or TG02, in patients with advanced/refractory hematologic malignancies has triggered a payment from S*BIO's development and commercialization partner for the program, Tragara Pharmaceuticals.

New method to synthesize drug candidates for testing

Some drugs may be more effective the longer they last inside the body. To prevent such drugs from being broken down too rapidly, pharmaceutical manufacturers often attach a fluorine-containing structure called a trifluoromethyl group. However, the processes now used require harsh reaction conditions or only work in a small number of cases, limiting their usefulness for synthesizing new drug candidates for testing.

Read more Medical News

› Verified 7 days ago